Search all content on GOV.UK

The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.

• Updated: 8 March 2022

Sir Hugh Taylor talks about the need for commitment and collaboration to make sure the Accelerated Access Review proposals become reality.

• Updated: 24 October 2016

First published during the 2016 to 2019 May Conservative government

Sets out recommendations to speed up access to innovative healthcare and technologies, to improve efficiency and outcomes for NHS patients.

• Updated: 24 October 2016

New recommendations set out how patients could get quicker access to innovative new diagnostic tools, treatments, and medical technologies.

• Updated: 24 October 2016

First published during the 2016 to 2019 May Conservative government

Lord Prior welcomes new ambitions to speed up patient access to innovative new treatments.

• Updated: 24 October 2016

First published during the 2016 to 2019 May Conservative government

This guide gives an overview of the innovation pathway for products to be used by the NHS.

• Updated: 25 May 2016

Proposals for accelerated access pathways for medicines, diagnostics, medical devices and digital products.

• Updated: 22 March 2016

Outlines the main themes in stakeholders' feedback to the Accelerated Access Review interim report.

• Updated: 22 March 2016

Looks at issues relating to the ethics of medicines adaptive pathways for patients (MAPPs) including the use of real world data.

• Updated: 22 March 2016

Assesses the practicality of recommendations from the Accelerated Access Review interim report.

• Updated: 22 March 2016